Shankar Siva, Radiation Oncologist at the Peter MacCallum Cancer Centre, shared on X about a recent paper by Jasmin Weindler et al. published on BMJ:
“Emerging PET tracers in RCC – CA-IX, PSMA and sestamibi – high sensitivity/specificity for renal mass characterization and staging. Is this what the future holds in kidney cancer? Out now Weindler at al.”
Title: Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma
Authors: Jasmin Weindler, Muhammad Ali, Cristian Udovicich, Michael S Hofman, Shankar Siva
More posts featuring Kidney Cancer.
